Entity type
Company
Filer Snapshot
Karuna Therapeutics, Inc.
CIK 0001771917. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.
Total filings
72
Latest filing
18 Mar 2024
Industry
Pharmaceutical Preparations
Filing-backed research brief
Start with the SEC data that changes for this CIK
Latest signal: SEC filing timeline only. Each card links back to the PortfolioSavvy page where the filing evidence is closest.
Latest 13F portfolio
—
No parsed 13F portfolio row yet.
Browse latest 13FLargest parsed holding
—
Populates from the latest parsed 13F information table.
Open holding13D/G large stake
—
No recent parsed 13D/G stake row for this CIK.
Browse 13D/GInsider / owner context
—
No parsed Forms 3/4/5 owner position for this CIK.
Browse insider filingsSave this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Source: SEC Forms 3/4/5
View Source Filing
4 filed on 18 Mar 2024 for CIK 0001771917.
- SEC industry
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 99 High Street, 26 Th Floor, Boston, MA, 02110
- Fiscal year-end
- 31 December
Identity
2 identity fields
SEC profile 1 profile field
Filer intelligence
What SEC filings say about Karuna Therapeutics, Inc.
A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.
SEC source mix
Counts show available parsed rows, not one combined ownership total.
13F portfolio
No rows yet
Quarterly institutional portfolio holdings.
13D/G stakes
No rows yet
Beneficial ownership and large-stake disclosures.
Forms 3/4/5
No rows yet
Officer, director, and 10% owner holdings or transactions.
No parsed ownership summary yet
We still show the SEC filing timeline below. The intelligence summary will populate when parsed 13F, 13D/G, or Forms 3/4/5 data exists for this CIK.
Latest update
What changed recently for Karuna Therapeutics, Inc.
Latest financial period: Q4 2023. Open the source-backed page to inspect the fresh filing or facts context.
Update date
22 Feb 2024
Page type
Company facts
Latest period
Q4 2023
SEC-backed company facts were refreshed from filings filed on 22 Feb 2024.
Benchmark Context
Benchmark context for this company
Karuna Therapeutics, Inc. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q4 2023. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 22 Feb 2024.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
SEC filing record
CIK 0001771917 filing coverage
Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.
SEC filings
72
First seen
12 May 2021
Latest filing
18 Mar 2024
Entity
Company
Observed form types
10-K/A
3
4
Industry context: Pharmaceutical Preparations.
Latest Filings
Showing the latest 12 of 72 SEC filings for Karuna Therapeutics, Inc..
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 15 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing
4
4 filing
- Filing date
- 18 Mar 2024
- Reporting date
- 18 Mar 2024
- SEC evidence
- Open document Open filing
- Next action
- Verify source filing